1.08
+0(+0.00%)
Currency In USD
| Previous Close | 1.08 |
| Open | 1.07 |
| Day High | 1.09 |
| Day Low | 1.01 |
| 52-Week High | 13.68 |
| 52-Week Low | 1.01 |
| Volume | 122,785 |
| Average Volume | 1.63M |
| Market Cap | 1.68B |
| PE | -2.45 |
| EPS | -0.44 |
| Moving Average 50 Days | 1.75 |
| Moving Average 200 Days | 4.16 |
| Change | 0 |
If you invested $1000 in Picard Medical, Inc. (PMI) since IPO date, it would be worth $235.29 as of March 03, 2026 at a share price of $1.08. Whereas If you bought $1000 worth of Picard Medical, Inc. (PMI) shares 6 months ago, it would be worth $204.16 as of March 03, 2026 at a share price of $1.08.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Picard Medical / SynCardia Showcases Leadership in Total Artificial Heart Therapy at Technology and Heart Failure Therapeutics Conference
GlobeNewswire Inc.
Yesterday at 1:00 PM GMT
New data highlight additional benefits beyond survival with the SynCardia Total Artificial Heart and preclinical progress for the next-generation Emperor systemTUCSON, Ariz., March 02, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: P
Perseverance Metals Upsizes Private Placement to up to C$7,500,000
Newsfile
Yesterday at 12:00 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - March 2, 2026) - Perseverance Metals Inc. (TSXV: PMI) ("Perseverance", "PMI" or the "Company") is pleased to announce that it has expanded its previously announced private placement of units (see PMI NR
Picard Medical / SynCardia to Participate in Inaugural “Hands-On Training Day” at the Technology and Heart Failure Therapeutics Conference
GlobeNewswire Inc.
Feb 26, 2026 1:00 PM GMT
– Training will consist of an interactive clinical education program highlighting real world application of the SynCardia Total Artificial Heart in advanced heart failure patients –TUCSON, Ariz., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Picard Medical, In